FDA ruling boosts Forbes marketing power
FDA approval for use of the phytosterol heart-health claim has given Canadian company Forbes Medi-Tech a major boost for its cholesterol-lowering ingredient Reducol.
Archives for March 3, 2003
Diet found guilty for obesity-related disease
Last week the WHO issued a controversial report on obesity and the impact of diet on health, suggesting we need to cut intake of saturated fats, salt and sugar and up fruit and veg. Health think-tank the International Obesity TaskForce says the...
Acrylamide movements
As research in laboratories across the globe continues into the presence of potential carcinogen acrylamide in a variety of foods, the US Food and Drug Administration (FDA) emphasised last week that consumers should continue to eat a balanced diet and...
Fatty diet plays role in infant mental function
A high-fat diet may explain the increased protection from damage caused by prolonged seizures in newborn brain cells, says a team of US researchers.
Enzymotec launches healthy oil
Israeli company Enzymotec has launched an ingredient derived from healthy fats for use in food applications. MultOil is based on natural oils enriched with phytosterols and DAG, both thought to help reduce the risk of cardiovascular disease.
Numico to sell Unicity
Dutch food group Royal Numico has signed a letter of intent for the sale of its US supplement business Unicity Network to an American investment company, Activated Holdings. The transaction is expected to complete in the second quarter of 2003.
WHO report - diet held responsible for obesity crisis
A new report from the World Health Organization lays the blame for the current obesity problem on our diet and suggests that the food industry should step up to the challenge to make food healthier.
Ephedra report - 'important' health risks
Following a new review on the safety of ephedra, the FDA has announced a series of actions which may tighten laws on the marketing of herb in supplements. Industry bodies have confirmed their support for the moves, which do not yet prohibit sale of...